81 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
2 May 24
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
6:03am
partners, or at all; and Aurinia’s assets or business activities may be subject to disputes that may result in litigation or other legal claims
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
15 Feb 24
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
6:06am
to disputes that may result in litigation or other legal claims. Although Aurinia has attempted to identify factors that would cause actual actions, events
8-K
EX-99.1
urdl6a2hwjg hlu7c
5 Jan 24
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2023 Net Revenue Results
6:02am
8-K
EX-99.1
7a285xv
2 Nov 23
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2023 Financial and Operational Results
6:01am
8-K
EX-10.1
snvuvmlgb9zpu 48e8pb
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
8-K
EX-99.1
luerd2xobtckh9q9
3 Aug 23
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2023 Financial and Operational Results
6:03am
8-K
EX-99.1
narm5
4 May 23
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results
6:06am
8-K
EX-99.1
bartf qwpynzeh6
3 Nov 22
Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results
6:04am
8-K
EX-99.1
951n87k
4 Aug 22
Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
6:07am